DP2-DP6-Enriched Maritime Pine Bark Microcapsules Support Keratinocyte Redox Control and a Nutritional Photoprotection Framework

photoprotection ultraviolet radiation maritime pine bark ROS minimal erythema dose

Authors

September 24, 2026

Downloads

Oral photoprotection depends on repeated delivery of compounds that can influence the skin response to ultraviolet stress. We examined a BCLC maritime pine bark microcapsule enriched in DP2-DP6 oligomeric proanthocyanidins. The reference material contained 62.4% DP2-DP6 within total proanthocyanidins, with low catechin/epicatechin and DP≥10 fractions. In H₂O₂-challenged HaCaT keratinocytes, intracellular ROS fell from the model value of 100% to 78.4%, 68.5% and 60.7% at 25, 50 and 100 μg/mL; cell viability remained above 93%. During simulated digestion, DP2-DP6 retention was 86.8% after the gastric phase and 78.6% after the intestinal phase. Human studies of standardized French maritime pine bark extract include an eight-week trial in which the ultraviolet dose required for one minimal erythema dose increased during supplementation and a randomized double-blind crossover study in outdoor workers reporting protection against seasonal skin darkening and deterioration of hydration/barrier parameters. The formulation and cell data place ingredient stability and keratinocyte redox control alongside established human photobiology endpoints for BCLC-specific evaluation.